Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
APID-COR
- Development stage
- Preclinical
- Lead developer
- Apidel
- Modality
- Hydrogel Systems → Drug Delivery Systems, Monoclonal Antibodies → Antibody-Based Therapeutics
- Administration
- Injectable
01
Overview
APID-COR refers to a preclinical-stage sustained-release injectable formulation of an undisclosed monoclonal antibody developed by Apidel. The product utilizes Apidel's proprietary APID-COR drug delivery technology, a biodegradable polymer-based system designed to provide controlled, long-term release of therapeutic proteins. This formulation aims to maintain therapeutic drug concentrations over several weeks or months from a single injection, potentially improving patient compliance and reducing the burden of frequent administration associated with standard monoclonal antibody therapies. As of the last available pipeline updates, the specific target antigen and therapeutic indication for this candidate have not been disclosed.
- Other names
- monoclonal antibody (APID-COR)Apidel monoclonal antibody sustained-release formulation
Beyond the preview
Go deeper on APID-COR.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on APID-COR.